Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Mid caps outperform
Mon, 29 Apr 11:30 am

Indian equity markets continued to trade in the green during the previous two hours of trade. Sectoral indices traded firm except metal and FMCG stocks.

The BSE-Sensex is trading higher by 61 points and NSE-Nifty is trading up by 17 points. BSE Mid Cap and BSE Small Cap indices are trading up by 0.5% and 0.3% respectively. The rupee is trading at 54.30 to the US dollar.

Steel stocks are trading strong led by Maharashtra Seamless and JSW Ispat. As per a leading daily, Tata Steel is planning to close down its technology centers in the UK over next 18 months. The steel company would shut down its 2 research and development centers in UK and shift them to other locations overseas. IT is expected to prefer Netherlands and India as the new locations of these centers. These technology centers are presently located at Teesside, in the north-east of England, and in Rotherham, South Yorkshire. This move is expected to result in the loss of 300-400 jobs in the UK. We may note here that Tata Steel is facing issues of high energy costs, falling demand and plummeting steel prices in Europe. The company is thus planning to shut down operations at a few sites resulting in 900 job losses.

Indian pharma stocks are trading strong led by Zandu Realty and Biocon Limited. As per a leading daily, Biocon is planning to launch psoriasis drug, Itolizumab branded as "Alzumab" in July. As per the management, this is a novel, first-in-class biologic for the treatment of psoriasis. The company will manufacture the drug at Biocon's bio-pharma facility in Biocon Park, Bangalore. We may note here that psoriasis is an inflammatory auto-immune skin disease that follows a typical relapsing and remitting course. The disease affects 2-3% of India's population. The drug finds huge market in India as well as abroad. Globally, the market size will be US$ 8 bn by 2016.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Mid caps outperform". Click here!


Related Views on News

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...


India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms


Mar 3, 2021 (Close)